Taken together, data from our current study support our hypothesis that systemic blockade of central and peripheral CB1 receptors has direct beneficial effects on blood pressure with a concomitant positive influence over metabolic profile in transgenic (mRen2)27 rats with Ang II‐dependent hypertension and features of metabolic syndrome. Here, AGT is linked to metabolic syndrome.